• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Feasibility and efficacy of extravascular implantable cardioverter-defibrillators in two patients with class III obesity.

作者信息

Gutierrez Omar, Cline Matthew, Amin Anish K

机构信息

MedOne Healthcare Partners, Department of Hospital Medicine, Columbus, Ohio.

Medtronic Inc, Mounds View, Minnesota.

出版信息

HeartRhythm Case Rep. 2024 May 28;10(8):561-563. doi: 10.1016/j.hrcr.2024.05.013. eCollection 2024 Aug.

DOI:10.1016/j.hrcr.2024.05.013
PMID:39155899
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11328540/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad52/11328540/e309caf2ca2d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad52/11328540/731ecfcedab3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad52/11328540/e309caf2ca2d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad52/11328540/731ecfcedab3/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ad52/11328540/e309caf2ca2d/gr2.jpg

相似文献

1
Feasibility and efficacy of extravascular implantable cardioverter-defibrillators in two patients with class III obesity.两名III级肥胖患者使用血管外植入式心脏复律除颤器的可行性和疗效
HeartRhythm Case Rep. 2024 May 28;10(8):561-563. doi: 10.1016/j.hrcr.2024.05.013. eCollection 2024 Aug.
2
Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).大多数植入式心脏复律除颤器/心脏再同步治疗除颤器患者可行无诱导或有限电击测试：多中心ASSURE研究（心律失常单次电击除颤阈值测试与易损性上限：植入式心脏复律除颤器植入的风险降低评估）结果
Circulation. 2007 May 8;115(18):2382-9. doi: 10.1161/CIRCULATIONAHA.106.663112. Epub 2007 Apr 30.
3
Non-traditional implantable cardioverter-defibrillator configurations and insertion techniques: a review of contemporary options.非传统型植入式心脏复律除颤器的配置和插入技术：当代选择的回顾。
Europace. 2022 Feb 2;24(2):181-192. doi: 10.1093/europace/euab178.
4
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
5
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy.血管外植入式心律转复除颤器：影响胸骨下植入和除颤效果的解剖参数特征。
Europace. 2022 May 3;24(5):762-773. doi: 10.1093/europace/euab243.
6
First-in-Human Chronic Implant Experience of the Substernal Extravascular Implantable Cardioverter-Defibrillator.首例经胸骨下入路植入式体外心脏除颤器的人体慢性植入经验。
JACC Clin Electrophysiol. 2020 Nov;6(12):1525-1536. doi: 10.1016/j.jacep.2020.05.029. Epub 2020 Aug 26.
7
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.体重指数对皮下植入式心脏除颤器的安全性和疗效的影响。
JACC Clin Electrophysiol. 2018 May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.
8
Defibrillation efficacy comparing a subcutaneous array electrode versus an "active can" implantable cardioverter defibrillator and a subcutaneous array electrode in addition to an "active can" implantable cardioverter defibrillator: results from active can versus array trials I and II.皮下阵列电极与“主动式除颤罐”植入式心律转复除颤器及皮下阵列电极联合“主动式除颤罐”植入式心律转复除颤器的除颤效果比较：主动式除颤罐与阵列试验I和II的结果
J Cardiovasc Electrophysiol. 2001 Aug;12(8):921-7. doi: 10.1046/j.1540-8167.2001.00921.x.
9
Initial Experience With Intercostal Insertion of an Extravascular ICD Lead Compatible With Existing Pulse Generators.经肋间植入与现有脉冲发生器兼容的血管外 ICD 导线的初步经验。
Circ Arrhythm Electrophysiol. 2023 Aug;16(8):421-432. doi: 10.1161/CIRCEP.123.011922. Epub 2023 Jul 24.
10
Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.植入式心脏复律除颤器治疗的风险分层：可穿戴式心脏除颤器的作用。
Eur Heart J. 2013 Aug;34(29):2230-42. doi: 10.1093/eurheartj/eht167. Epub 2013 May 31.

本文引用的文献

1
Subcutaneous implantable cardioverter-defibrillator implantation position predicts successful defibrillation in obese and non-obese patients.皮下植入式心律转复除颤器的植入位置可预测肥胖和非肥胖患者的除颤成功率。
J Interv Card Electrophysiol. 2025 Aug;68(5):1009-1015. doi: 10.1007/s10840-022-01462-z. Epub 2023 Jan 3.
2
Efficacy and Safety of an Extravascular Implantable Cardioverter-Defibrillator.经静脉植入式心脏复律除颤器的疗效和安全性。
N Engl J Med. 2022 Oct 6;387(14):1292-1302. doi: 10.1056/NEJMoa2206485. Epub 2022 Aug 28.
3
Three-year extraction experience of a novel substernal extravascular defibrillation lead in sheep.
新型胸骨下血管外除颤电极导线在绵羊体内 3 年的取出经验。
Pacing Clin Electrophysiol. 2022 Mar;45(3):314-322. doi: 10.1111/pace.14451. Epub 2022 Feb 8.
4
Factors Associated With High-Voltage Impedance and Subcutaneous Implantable Defibrillator Ventricular Fibrillation Conversion Success.与高电压阻抗和皮下植入式除颤器心室颤动转复成功相关的因素。
Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e006665. doi: 10.1161/CIRCEP.118.006665.
5
A novel tool to evaluate the implant position and predict defibrillation success of the subcutaneous implantable cardioverter-defibrillator: The PRAETORIAN score.一种评估皮下植入式心律转复除颤器植入位置和预测除颤效果的新工具：PRAETORIAN 评分。
Heart Rhythm. 2019 Mar;16(3):403-410. doi: 10.1016/j.hrthm.2018.09.029. Epub 2018 Oct 4.
6
Impact of Body Mass Index on Safety and Efficacy of the Subcutaneous Implantable Cardioverter-Defibrillator.体重指数对皮下植入式心脏除颤器的安全性和疗效的影响。
JACC Clin Electrophysiol. 2018 May;4(5):652-659. doi: 10.1016/j.jacep.2017.11.019. Epub 2018 Feb 2.
7
High defibrillation threshold with a subcutaneous implantable cardiac defibrillator due to the lead having been positioned in the fat layer.皮下植入式心脏除颤器出现高除颤阈值，原因是导线放置在了脂肪层。
J Arrhythm. 2018 Feb 8;34(2):198-200. doi: 10.1002/joa3.12033. eCollection 2018 Apr.
8
Totally submuscular implantation of subcutaneous implantable cardioverter defibrillator: a safe and effective solution for obese or oversized patients.皮下植入式心律转复除颤器完全肌下植入：肥胖或体型过大患者的安全有效解决方案。
Clin Case Rep. 2016 Sep 17;4(10):1009-1011. doi: 10.1002/ccr3.652. eCollection 2016 Oct.
9
Failed Maximal Defibrillation Threshold Testing in the Subcutaneous Implantable Cardioverter Defibrillator.皮下植入式心律转复除颤器最大除颤阈值测试失败
Cardiology. 2017;136(1):29-32. doi: 10.1159/000447484. Epub 2016 Aug 23.